THE GREATEST GUIDE TO AGO TUMOR

Molecular typing is based on molecular genetic testing and isn't nevertheless routinely available. Molecular subtypes and immunohistochemical surrogate markers of the tumors (HR, HER2, triple unfavorable) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-sixty seven might be handy